| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9073696 | Clinical Nutrition | 2005 | 9 Pages |
Abstract
Conclusions: In patients with end-stage liver disease, our results suggest the possibility that Impact may have a role in improving preoperative nutritional status, hastening recovery after transplant, and reducing postoperative infectious complications. These potential benefits need to be confirmed in a randomised controlled trial.
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Lindsay D. Plank, John L. McCall, Edward J. Gane, Mohammad Rafique, Lynn K. Gillanders, Kerry McIlroy, Stephen R. Munn,